EDUC vs JAZZ · P/E 5.4, rev $22.9M vs P/E 1988, rev $4.07B
Educational Development Corporation (EDUC) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Educational Development Corporation (EDUC) is a publishing company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported EDUC revenue for 2026-02-28 was $22.9M. Net income was $2.3M. Revenue was up 245.3% from 2025-02-28 to 2026-02-28. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
EDUC currently screens at market cap $12.3M and trailing P/E 5.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the EDUC and JAZZ stock pages for the full models.
Not investment advice.